scholarly journals Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas

1998 ◽  
Vol 4 (3) ◽  
Author(s):  
Alan R. Hinman ◽  
Bradley S. Hersh ◽  
Ciro A. de Quadros
Keyword(s):  
Congenital Rubella Syndrome ◽  
Rubella Vaccine ◽  
Rational Use ◽  
Congenital Rubella

scholarly journals EDUKASI PEMBERIAN IMUNISASI MR (MEASLES RUBELLA) PADA IBU YANG MEMILIKI ANAK USIA BALITA

2021 ◽  
Vol 3 (1) ◽  
pp. 45
Author(s):  
Melia Pebrina ◽  
Fenny Fernando ◽  
Annisa Novita Sary
Keyword(s):  
Community Service ◽  
Health Workers ◽  
Immunization Coverage ◽  
Congenital Rubella Syndrome ◽  
Rubella Vaccine ◽  
Under Five ◽  
Measles Elimination ◽  
Congenital Rubella ◽  
And Control ◽  
Immunization Campaign

Campak dan Rubella merupakan penyakit infeksi menular melalui saluran nafas yang disebabkan oleh virus Campak dan Rubella.Vaksin MR (Measles Rubella) memberikan manfaat seperti dapat melindungi anak dari kecacatan dan kematian akibat komplikasi pneumonia, diare, kerusakan otak, ketulian, kebutaan, dan penyakit jantung bawaan. Indonesia telah berkomitmen untuk mencapai eliminasi campak dan pengendalian rubella/Congenital Rubella Syndrome (CRS) pada tahun 2020. Berdasarkan hasil surveilans dan cakupan imunisasi, maka imunisasi campak rutin saja belum cukup untuk mencapai target eliminasi campak. Sedangkan untuk akselerasi pengendalian rubella/CRS maka perlu dilakukan kampanye imunisasi tambahan sebelum introduksi vaksin MR ke dalam imunisasi rutin. Program Pengabdian Masyarakat ini melalui penerapan Ipteks bagi masyarakat bertujuan mengenalkan dan tercapainya cakupan imunisasi measles rubella. Kegiatan pengabmas dilaksanakan hari Rabu  tanggal 18 Februari 2021 pukul 10.00 Wib, tempat pelaksanaan di Puskesmas Nanggalo Padang. Peserta yang hadir jumlah 15 orang ibu-ibu yang mempunyai anak usia balita. Berdasarkan hasil kegiatan tersebut terjadinya peningkatan pengetahuan ibu yang mempunyai anak usia balita tentang pemberian imunisasi MR. Diharapkan petugas kesehatan meningkatkan edukasi tentang pemberian imunisasi MR.  Kata Kunci: Imunisasi MR (Measles Rubella)  ABSTRACT Measles and Rubella are infectious diseases that are transmitted through the respiratory tract caused by the measles and rubella viruses. The MR (Measles Rubella) vaccine provides benefits such as protecting children from disability and death due to complications of pneumonia, diarrhea, brain damage, deafness, blindness and heart disease. built-in. Indonesia has committed to achieve elimination of measles and control of rubella / Congenital Rubella Syndrome (CRS) by 2020. Based on the results of surveillance and immunization coverage, routine measles immunization alone is not sufficient to achieve the target of measles elimination. Meanwhile, for the acceleration of rubella / CRS control, it is necessary to carry out an additional immunization campaign before the introduction of the MR vaccine into routine immunization. This Community Service Program through the application of science and technology for the community aims to introduce and achieve measles rubella immunization coverage. Community service activities will be carried out on Wednesday, February 18, 2021 at 10.00 WIB, the place of implementation is at the Nanggalo Padang Health Center. Participants who attended were 15 mothers who have children under five. Based on the results of these activities there is an increase in the knowledge of mothers who have children aged under five about giving MR immunization. It is hoped that health workers will increase education about MR immunization. Keywords: immunization MR (Measles Rubella)Campak dan Rubella merupakan penyakit infeksi menular melalui saluran nafas yang disebabkan oleh virus Campak dan Rubella.Vaksin MR (Measles Rubella) memberikan manfaat seperti dapat melindungi anak dari kecacatan dan kematian akibat komplikasi pneumonia, diare, kerusakan otak, ketulian, kebutaan, dan penyakit jantung bawaan. Indonesia telah berkomitmen untuk mencapai eliminasi campak dan pengendalian rubella/Congenital Rubella Syndrome (CRS) pada tahun 2020. Berdasarkan hasil surveilans dan cakupan imunisasi, maka imunisasi campak rutin saja belum cukup untuk mencapai target eliminasi campak. Sedangkan untuk akselerasi pengendalian rubella/CRS maka perlu dilakukan kampanye imunisasi tambahan sebelum introduksi vaksin MR ke dalam imunisasi rutin. Program Pengabdian Masyarakat ini melalui penerapan Ipteks bagi masyarakat bertujuan mengenalkan dan tercapainya cakupan imunisasi measles rubella. Kegiatan pengabmas dilaksanakan hari Rabu  tanggal 18 Februari 2021 pukul 10.00 Wib, tempat pelaksanaan di Puskesmas Nanggalo Padang. Peserta yang hadir jumlah 15 orang ibu-ibu yang mempunyai anak usia balita. Berdasarkan hasil kegiatan tersebut terjadinya peningkatan pengetahuan ibu yang mempunyai anak usia balita tentang pemberian imunisasi MR. Diharapkan petugas kesehatan meningkatkan edukasi tentang pemberian imunisasi MR.  Kata Kunci: Imunisasi MR (Measles Rubella)  ABSTRACT Measles and Rubella are infectious diseases that are transmitted through the respiratory tract caused by the measles and rubella viruses. The MR (Measles Rubella) vaccine provides benefits such as protecting children from disability and death due to complications of pneumonia, diarrhea, brain damage, deafness, blindness and heart disease. built-in. Indonesia has committed to achieve elimination of measles and control of rubella / Congenital Rubella Syndrome (CRS) by 2020. Based on the results of surveillance and immunization coverage, routine measles immunization alone is not sufficient to achieve the target of measles elimination. Meanwhile, for the acceleration of rubella / CRS control, it is necessary to carry out an additional immunization campaign before the introduction of the MR vaccine into routine immunization. This Community Service Program through the application of science and technology for the community aims to introduce and achieve measles rubella immunization coverage. Community service activities will be carried out on Wednesday, February 18, 2021 at 10.00 WIB, the place of implementation is at the Nanggalo Padang Health Center. Participants who attended were 15 mothers who have children under five. Based on the results of these activities there is an increase in the knowledge of mothers who have children aged under five about giving MR immunization. It is hoped that health workers will increase education about MR immunization. Keywords: immunization MR (Measles Rubella)

scholarly journals Anti-Rubella IgM status in antenatal checkup visiting women

1970 ◽  
Vol 7 (2) ◽  
pp. 76-79
Author(s):  
KP KC ◽  
S Malla ◽  
P Ghimire ◽  
SP Khanal ◽  
SP Dumre
Keyword(s):  
Pregnant Women ◽  
Congenital Rubella Syndrome ◽  
Serum Samples ◽  
Rubella Vaccine ◽  
Recent Infection ◽  
Rubella Infection ◽  
Congenital Rubella ◽  
Health Research Council ◽  
Adult Immunization ◽  
Standard Operating Protocol

Background: Rubella is a viral infection. Congenital rubella syndrome is the most serious consequences of rubella which has been observed in pregnant women. This study has been done to reveal the association of rubella infection in women. Methods: The serum specimens were collected from women during their regular antenatal check up, in, was included in the study. Specimens were tested at NPHL every week following standard operating protocol of NPHL utilizing Human ELISA (German) kits and reagents. The results of the tests along with the clinical histories collected from the patient on a proforma file carried by the patients were analyzed following standard statistical tools. Results: During the three years study period, 320 serum samples were collected in 2006, 372 in 2007 and 400 in 2008, out of which 38 (11.87%), 72 (19.35%) and 49 (12.25%) of the women visiting NPHL during their antenatal checkup were found positive to anti-rubella IgM antibody respectively, indicating recent infection. Almost above 80% of the positive cases were from age group 20-30 years. Conclusions: The study showed the significant association of recent rubella infection in women which emphasizes requirement of adolescent or adult immunization with rubella vaccine at the earliest. Key words: anti-rubella IgM; congenital rubella syndrome; pregnant women; rubella. DOI: 10.3126/jnhrc.v7i2.3010 Journal of Nepal Health Research Council Vol.7(2) Apr 2009 76-79

scholarly journals Epidemio-clinical aspects of congenital rubella syndrome in Madagascar

2020 ◽  
Vol 8 (2) ◽  
pp. 424
Author(s):  
Todisoa N. Andriatahina ◽  
Lantonirina Ravaoarisoa ◽  
Andrianina H. Ranivoson ◽  
Vonintsoa L. Rahajamanana ◽  
Zina A. Randriananahirana ◽  
...  
Keyword(s):  
Congenital Rubella Syndrome ◽  
World Health ◽  
Clinical Aspects ◽  
Age Group ◽  
Pediatric Practice ◽  
Rubella Vaccine ◽  
Clinical Criteria ◽  
Congenital Rubella ◽  
Expanded Program On Immunization ◽  
Health Organization

Background: Congenital rubella syndrome is the first congenital defect preventable by vaccination. The purpose of this study was to provide basic information on the extent and epidemiology of congenital rubella syndrome in Madagascar.Methods: A retrospective and descriptive study from January 2013 to May 2019 was conducted in 8 hospitals in 2 provinces of Madagascar, Antananarivo and Toliara. The study included children who attended the services selected during the study period and who had the following conditions: children aged of 0 to 59 months, regardless of vaccination status, meeting the World Health Organization clinical criteria for congenital rubella syndrome with or without biological confirmation.Results: Of the 152,304 cases of children of all ages who visited or were hospitalized during the study period, 112 clinically confirmed cases of congenital rubella syndrome were identified. The age group 0 to 11 months involved 60 children (53.6%). Congenital heart disease was found in 83.0% of cases, mental backwardness in 43.7% and microcephaly in 26.8%. Twenty-three among (20.5%) them died. The death was due to cardiac diseases in 16 children.Conclusions: Findings confirm that the diagnosis of congenital rubella syndrome is underestimated in current pediatric practice in Madagascar. The introduction of the rubella vaccine in the Expanded Program on Immunization and the implementation of an effective and sustainable surveillance system for congenital rubella syndrome in the country is a proved effective tool for the prevention of this disease.

scholarly journals Rubella infection: Advances and challenges in the diagnosis and prevention of Congenital Rubella Syndrome

2020 ◽  
Vol 4 (1) ◽  
pp. 006-013
Author(s):  
Vueba Amélia Nkutxi ◽  
do Céu Sousa Maria
Keyword(s):  
Disease Transmission ◽  
Laboratory Diagnosis ◽  
Congenital Rubella Syndrome ◽  
Vaccination Program ◽  
Rubella Vaccine ◽  
Vaccination Programs ◽  
Rubella Infection ◽  
Congenital Rubella ◽  
The World ◽  
Rubella Vaccination

Rubella remains an important pathogen worldwide, with many cases of congenital rubella syndrome per year. Rubella vaccination is included in the vaccination program of many countries. WHO has set goals for the elimination of measles and rubella and prevention of congenital rubella syndrome by 2020. Worldwide, the rubella vaccine is highly effective and safe, and as a result, endemic rubella transmission has been halted in the Americas since 2009. Incomplete rubella vaccination programs result in continuous disease transmission, as evidenced by major recent outbreaks in some countries around the world. In this review, we present the rubella control, elimination and eradication policies and a brief review of the rubella laboratory diagnosis.

Burden of Congenital Rubella Syndrome (CRS) in Bangladesh: Systematic Review of Existing Literature and Transmission Modelling of Seroprevalence Studies

2020 ◽  
Vol 20 (3) ◽  
pp. 284-290
Author(s):  
Jocelyn Chan ◽  
Yue Wu ◽  
James Wood ◽  
Mohammad Muhit ◽  
Mohammed K. Mahmood ◽  
...  
Keyword(s):  
Systematic Review ◽  
Deterministic Model ◽  
Case Series ◽  
Controlled Vocabulary ◽  
Congenital Rubella Syndrome ◽  
Free Text ◽  
Childbearing Age ◽  
Vaccination Programs ◽  
Congenital Rubella ◽  
The Impact

Background and Objectives: Congenital Rubella Syndrome (CRS) is the leading cause of vaccine-preventable congenital anomalies. Comprehensive country-level data on the burden of CRS in low and middle-income countries, such as Bangladesh, are scarce. This information is essential for assessing the impact of rubella vaccination programs. We aim to systematically review the literature on the epidemiology of CRS and estimate the burden of CRS in Bangladesh. Methods: We conducted a systematic review of existing literature and transmission modelling of seroprevalence studies to estimate the pre-vaccine period burden of CRS in Bangladesh. OVID Medline (1948 – 23 November 2016) and OVID EMBASE (1974 – 23 November 2016) were searched using a combination of the database-specific controlled vocabulary and free text terms. We used an age-stratified deterministic model to estimate the pre-vaccination burden of CRS in Bangladesh. Findings: Ten articles were identified, published between 2000 and 2014, including seven crosssectional studies, two case series and one analytical case-control study. Rubella seropositivity ranged from 47.0% to 86.0% among all age population. Rubella sero–positivity increased with age. Rubella seropositivity among women of childbearing age was 81.0% overall. The estimated incidence of CRS was 0·99 per 1,000 live births, which corresponds to approximately 3,292 CRS cases annually in Bangladesh. Conclusion: The estimated burden of CRS in Bangladesh during the pre-vaccination period was high. This will provide important baseline information to assess the impact and cost-effectiveness of routine rubella immunisation, introduced in 2012 in Bangladesh.

Sign in / Sign up

Export Citation Format

Share Document